News

  • Comments on PRN 2012

    June 13, 2012
      June 13, 2012 Robert Melillo, Chief Legislation and Regulation New Jersey Department of Banking and Insurance 20 West State Street P.O. Box 325 Trenton, New Jersey 08625-0325   Sent via e-mail to: LegsRegs@dobi.state.nj.us RE: PRN 2012-066, Proposed Amendments: N.J.A.C. 11:22-1.1, 1.2, and 1.4   Dear Mr. Melillo,   The American Clinical Laboratory Association (“ACLA”) appreciates the opportunity to comment on the above-referenced ruleContinue Reading »...
  • Letter to FACA Program Lead Regarding McCaslin Nomination HITSC 2012

    June 08, 2012
      June 8, 2012   MacKenzie Robertson FACA Program Lead Office of the National Coordinator 355 E Street, SW, Suite 310 Washington, D.C. 20024   Dear Mr. Robertson: American Clinical Laboratory Association June 8, 2012 As President of the American Clinical Laboratory Association (ACLA), I am writing to urge that you appoint a representative of the laboratory industry as a Member to the HealthContinue Reading »...
  • Letter to Jon Blum Regarding Mitchell Study

    June 01, 2012
      June 1,2012   Jonathan D. Blum Centers for Medicare & Medicaid Services Director, Center for Medicare Management Mail Stop 314G 200 Independence Avenue, S.W. Washington, D.C. 20201   Dear Jon: Thank you very much for meeting with representatives of the College of American Pathologists and ACLA last week. We thought it was a very useful meeting and appreciated the opportunity to discuss pathologyContinue Reading »...
  • Comments to HHS on HPID and ICD-10 Extension Proposed Rule

    May 17, 2012
      May 17, 2012 Centers for Medicare and Medicaid Services Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Avenue, SW Washington, DC 20201 Re: File Code CMS-0040-P RIN 0938-AQ13 Administrative Simplification: Adoption of a Standard for a Unique Health Plan Identifier; Addition to the National Provider Identifier Requirements; and a Change to the Compliance Date for ICD-10-CM andContinue Reading »...
  • Comments Regarding Taxable Medical Devices

    May 07, 2012
      May 7, 2012 Steven T. Miller Deputy Commissioner for Services and Enforcement Internal Revenue Service 1111 Constitution Avenue, NW Washington, DC Submitted electronically via www.regulations.gov (IRS REQ-i 13770-JO) Re:       Taxable Medical  Devices;  CC:PA:I2PD:PR  (REC—113770-10). Dear Deputy Commissioner Miller: On behalf of the American Clinical Laboratory Association (“ACLA”), I am pleased to provide these comments in connection with the Internal Revenue Service’s (“IRS”) Notice of ProposedContinue Reading »...
  • ACLA Urges Health Subcommittee to Adopt Provisions on User-Fees and Laboratory- Developed Tests

    May 07, 2012
    Washington DC – The American Clinical Laboratory Association today urged the House Energy and Commerce Health Subcommittee to approve provisions in its device user-fee legislation that would allow HHS to waive user fees for clinical laboratories and lab-developed tests (LDTs), and that would further require FDA to notify Congress 60 days prior to issuing a guidance on the regulation of LDTs. ACLA conveyed itsContinue Reading »...
  • Letter to Chairman Pitts and Ranking Member Pallone Regarding MDUFA

    May 07, 2012
      May 7, 2012   The Honorable Joe Pitts Chairman Subcommittee on Health Committee on Energy and Commerce U.S. House of Representatives 2125, Rayburn House Office Building Washington, DC 20515 The Honorable Frank Pallone, Jr. Ranking Member Subcommittee on Health Committee on Energy and Commerce U.S. House of Representatives 2322-A, Rayburn House Office Building Washington, DC 20515   Dear Chairman Pitts and Ranking MemberContinue Reading »...
  • Comments on MU Stage 2

    May 04, 2012
      May 4, 2012 Ms. Marilyn Tavenner, Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attn: CMS-0044-P P.O. Box 8013 Baltimore, Maryland 21244-8013 RE: RIN 0938-AQ84: Medicare and Medicaid Programs; Electronic Health Record Incentive Program—Stage 2 Dear Ms. Tavenner: The American Clinical Laboratory Association (“ACLA”) appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’Continue Reading »...
  • Comments on EHR Certification 2014 Edition

    May 04, 2012
      May 4, 2012 Dr. Farzad Mostashari, National Coordinator for Health Information Technology Office of the National Coordinator for Health Information Technology Department of Health and Human Services Attn: 2014 Edition EHR Standards and Certification Criteria Proposed Rule Hubert H. Humphrey Building, Ste. 729D 200 Independence Avenue SW Washington, DC 20201 RE: RIN 0991-AB82: Health Information Technology: Standards, Implementation Specifications, and Certification Criteria forContinue Reading »...
  • Comments on Overpayments Proposed Rule

    April 16, 2012
      April 16, 2012 Ms. Marilyn Tavenner, Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-6037-P P.O. Box 8013 Baltimore, Maryland 21244-8013 RE: RIN 0938-AQ58: Medicare Program; Reporting and Returning Overpayments Dear Ms. Tavenner, The American Clinical Laboratory Association (“ACLA”) appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’ (“CMS’s” or “the agency’s”)Continue Reading »...